These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8951704)

  • 1. Quantitative estimation of sultamicillin p-toluenesulfonate in pharmaceutical preparations by reverse-phase high performance liquid chromatography.
    Argekar AP; Kunjir SS
    J Pharm Biomed Anal; 1996 Dec; 15(3):423-7. PubMed ID: 8951704
    [No Abstract]   [Full Text] [Related]  

  • 2. HPLC for in-process control in the production of sultamicillin.
    Laviana L; Fernández-Marí F; Bayod M; Blanco D
    J Pharm Biomed Anal; 2003 Feb; 31(2):321-8. PubMed ID: 12609671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of micellar electrokinetic chromatography to the determination of sultamicillin in oral pharmaceutical preparations.
    Pajchel G; Tyski S
    J Chromatogr A; 2002 Dec; 979(1-2):315-21. PubMed ID: 12498263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CE versus LC for simultaneous determination of amoxicillin/clavulanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections.
    Pajchel G; Pawłowski K; Tyski S
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):75-81. PubMed ID: 12062667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of sultamicillin tosylate in artificial gastric and intestinal media.
    Güven KC; Temiz D
    Pharmazie; 1991 Apr; 46(4):295. PubMed ID: 1886922
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on sultamicillin hydrolysis].
    Hu CQ; Yang MZ; Zhang DC; Liu W; Wu Q; Liang H; Jin SH
    Yao Xue Xue Bao; 1997 Jul; 32(7):553-7. PubMed ID: 11596284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of ampicillin, cefoperazone, and sulbactam in pharmaceutical formulations by HPLC with beta-cyclodextrin stationary phase.
    Tsou TL; Huang YC; Lee CW; Lee AR; Wang HJ; Chen SH
    J Sep Sci; 2007 Oct; 30(15):2407-13. PubMed ID: 17685376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the formulation on the bioequivalence of sultamicillin: tablets and suspension.
    Koytchev R; Ozalp Y; Erenmemisoglu A; Kunter U; Alpan RS
    Arzneimittelforschung; 2004 Sep; 54(9A):634-9. PubMed ID: 15497673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UV-spectrophotometric determination of ampicillin sodium and sulbactam sodium in two-component mixtures.
    Mahgoub H; Aly FA
    J Pharm Biomed Anal; 1998 Sep; 17(8):1273-8. PubMed ID: 9800647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of ampicillin and sulbactam by liquid chromatography: post-column reaction with sodium hydroxide and sodium hypochlorite using an active hollow-fibre membrane reactor.
    Haginaka J; Nishimura Y
    J Chromatogr; 1990 Oct; 532(1):87-94. PubMed ID: 2079542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation.
    Ficarra R; Ficarra P; Tommasini S; Melardi S; Calabrò ML; Furlanetto S; Semreen M
    J Pharm Biomed Anal; 2000 Aug; 23(1):169-74. PubMed ID: 10898167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance.
    Kumar VJ; Gupta PB; Kumar KS; Ray UK; Sreenivasulu B; Kumar GS; Rao KR; Sharma HK; Mukkanti K
    J Pharm Biomed Anal; 2011 Feb; 54(3):582-7. PubMed ID: 20934824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fractional wavelet approach for the simultaneous determination of ampicillin sodium and sulbactam sodium in a binary mixture.
    Dinç E; Baleanu D
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Mar; 63(3):631-8. PubMed ID: 16024281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of sultamicillin.
    Lode H; Hampel B; Bruckner G; Koeppe P
    APMIS Suppl; 1989; 5():17-22. PubMed ID: 2660866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic assay of ampicillin and its prodrug lenampicillin.
    Marzo A; Monti N; Ripamonti M; Arrigoni Martelli E; Picari M
    J Chromatogr; 1990 May; 507():235-9. PubMed ID: 2380291
    [No Abstract]   [Full Text] [Related]  

  • 17. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultraviolet spectrophotometry (dual wavelength and chemometric) and high performance liquid chromatography for simultaneous estimation of meropenem and sulbactam sodium in pharmaceutical dosage form.
    Marwada KR; Patel JB; Patel NS; Patel BD; Borkhatariya DV; Patel AJ
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Apr; 124():292-9. PubMed ID: 24495837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide clinical experience with sultamicillin.
    Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
    APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
    Nageswara Rao R; Narasa Raju A; Narsimha R
    J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.